Today’s Research Reports on Trending Tickers: Spectrum Pharmaceuticals and Tesaro

NEW YORK, NY / ACCESSWIRE / June 7, 2018 / U.S. equities closed in the green on Wednesday, as bond yields rose pushing financial sector higher. The Dow Jones Industrial Average jumped 1.40 percent to close at 25,146.39, logging its biggest one-day gain since April 10, while the S&P 500 Index climbed 0.86 percent to close at 2,772.35. The Nasdaq Composite Index was up 0.67 percent to close at 7,689.24.

”While investors continue to watch trade developments, it’s really the rise in bond yields that is supporting the market today. The indication that the ECB could reduce bond purchases as early as next week has allowed long-term rates to move up, and that’s driving financials higher, as higher rates support their outlook,” said Kate Warne, investment strategist at Edward Jones.

”We’re still in the stage of the economy where rising rates reflect stronger economic growth, as opposed to central banks trying to combat inflation. The ECB news is a relief rather than a worry,” Warne added.

RDI Initiates Coverage on:

Spectrum Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=SPPI

Tesaro, Inc.
https://rdinvesting.com/news/?ticker=TSRO

Spectrum Pharmaceuticals’ stock jumped 4.66% Wednesday, to close the day at $20.20. The stock recorded a trading volume of 1,976,060 shares, which was above its three months average volume of 1,708,907 shares. In the last year, Spectrum Pharmaceuticals’ shares have traded in a range of 5.87 – 23.50. The share price has gained 244.12% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $18.07 is below its 200-day moving average of $18.95. Shares of Spectrum Pharmaceuticals have gained roughly 23.02 percent in the past month and are up 6.6 percent year-to-date.

Access RDI’s Spectrum Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SPPI

On Wednesday, shares of Tesaro recorded a trading volume of 1,365,134 shares, which was above the three months average volume of 1,294,893 shares. The stock ended the day 3.34% higher at $43.98. The share price has fallen 71.44% from its 52 week high with a 52 week trading range of 42.13 – 153.98. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $49.18 is below its 200-day moving average of $63.37. Shares of Tesaro have fallen roughly 11.97 percent in the past month and are down 46.93 percent year-to-date.

Access RDI’s Tesaro, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=TSRO

Our Actionable Research on Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and Tesaro, Inc. (NASDAQ: TSRO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 502009